Moderna (MRNA) Net Cash Flow (QoQ) (2018 - 2026)
Moderna (MRNA) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Moderna |
25.27 Bn |
20.06 Bn |
-566.00 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-147.10% |
| Dec 31, 2025 |
1,088.51% |
| Sep 30, 2025 |
57.23% |
| Jun 30, 2025 |
-14.19% |
| Mar 31, 2025 |
-207.07% |
| Dec 31, 2024 |
133.93% |
| Sep 30, 2024 |
-303.91% |
| Jun 30, 2024 |
147.72% |
| Mar 31, 2024 |
-3,328.00% |
| Dec 31, 2023 |
97.12% |
| Sep 30, 2023 |
-340.72% |
| Jun 30, 2023 |
47.95% |
| Mar 31, 2023 |
38.64% |
| Dec 31, 2022 |
12.82% |
| Sep 30, 2022 |
107.17% |
| Jun 30, 2022 |
-20.83% |
| Mar 31, 2022 |
-238.57% |
| Dec 31, 2021 |
2,550.94% |
| Sep 30, 2021 |
-132.92% |
| Jun 30, 2021 |
-94.28% |
